Atomwise adds Raj Ganguly to its Board along with raising $123m Series B financing led by B Capital Group and Sanabil Investments

– USA, CA –  Atomwise, the company deciphering human disease via the largest AI-drug discovery portfolio, today announced that it has closed $123 million in an oversubscribed Series B financing led by B Capital Group and Sanabil Investments alongside returning investors DCVC, BV, Tencent, Y Combinator, Dolby Family Ventures, AME Cloud Ventures, as well as new backing from two top ten global insurance companies.…